Comment on

• Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

  Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L. Slamon DJ, et al. N Engl J Med. 2001 Mar 15;344(11):783-92. doi: 10.1056/NEJM200103153441101. N Engl J Med. 2001. PMID: 11248153 Clinical Trial.
• From the molecule to the clinic--inhibiting HER2 to treat breast cancer.

  Eisenhauer EA. Eisenhauer EA. N Engl J Med. 2001 Mar 15;344(11):841-2. doi: 10.1056/NEJM200103153441110. N Engl J Med. 2001. PMID: 11248162 No abstract available.